ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2025

Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST study.

S Gerdes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.